{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:26:21Z","timestamp":1792106781455,"version":"4.4.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["1158"],"award-info":[{"award-number":["1158"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Fibromyalgia syndrome (FMS) is a complex chronic pain condition characterized by widespread pain and tenderness, fatigue, and sleep disturbances. Currently, factors contributing to FMS are considered to be multifactorial, and the involvement of inflammatory processes is a question of debate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The aims of this study were (1) to assess whether serum concentrations of high-sensitivity C-reactive protein (hsCRP) differ between individuals diagnosed with FMS and pain-free controls, (2) to determine whether these differences are associated with clinical symptoms, and (3) to explore whether the observed differences can be explained by specific covariates such as age, weight, and smoking status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An ANOVA was applied to identify differences of hsCRP levels between FMS and pain-free controls and an analysis of covariance (ANCOVA) was performed to investigate the dependencies of hsCRP with respect to covariates. To assess the reliability of our findings, we also utilized a Bayesian robust estimation model to determine the level of confidence associated with our results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results showed that individuals with FMS had higher hsCRP levels compared to healthy controls [<jats:italic>F<\/jats:italic>(1,106)\u2009=\u20098.802, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001] and that higher hsCRP levels were significant correlated with a higher symptom burden (<jats:italic>r<\/jats:italic>\u2009=\u20090. 287, <jats:italic>p<\/jats:italic>\u2009=\u20090.008) and more tender points (<jats:italic>r<\/jats:italic>\u2009=\u20090.307, <jats:italic>p<\/jats:italic>\u2009=\u20090.005). Further, hsCRP levels were significantly associated with weight (\u03b7<jats:sup>2<\/jats:sup>\u2009=\u20090.154, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001), but independent of age (\u03b7<jats:sup>2<\/jats:sup>\u2009=\u20090.005, <jats:italic>p<\/jats:italic>\u2009=\u20090.42), smoking status (\u03b7<jats:sup>2<\/jats:sup>\u2009=\u20090.002, <jats:italic>p<\/jats:italic>\u2009=\u20090.623), or gender (\u03b7<jats:sup>2<\/jats:sup>\u2009=\u20090.0045, <jats:italic>p<\/jats:italic>\u2009=\u20090.437), which resulted in an insignificant group effect between FMS and controls (\u03b7<jats:sup>2<\/jats:sup>\u2009=\u20090.029, <jats:italic>p<\/jats:italic>\u2009=\u20090.052), even after controlling for covariates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In conclusion, this study provides evidence that sub-inflammatory processes correlate with clinical symptoms, which can be partly attributed to differences in weight, but cannot be fully explained by them. Further research is needed to elucidate the mechanisms underlying the association between hsCRP and FMS and to explore the potential therapeutic implications of targeting hsCRP in the management of FMS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1237518","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T08:12:54Z","timestamp":1701331974000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Elevated high sensitive C-reactive protein in fibromyalgia"],"prefix":"10.3389","volume":"14","author":[{"given":"Eva","family":"Beiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Brenner Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Christoph","family":"Friederich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Tesarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PerPAIN Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.rbre.2017.01.005","article-title":"Prevalence of fibromyalgia: literature review update","volume":"57","author":"Marques","year":"2017","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/PRBM.S178240","article-title":"Psychological impact of fibromyalgia: current perspectives","volume":"12","author":"Galvez-S\u00e1nchez","year":"2019","journal-title":"Psychol Res Behav Manag"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"JITC33","DOI":"10.7326\/IsTranslatedFrom_AITC202003030_Japanese","article-title":"Fibromyalgia (Japanese version)","volume":"172","author":"Bair","year":"2020","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1097\/j.pain.0000000000001819","article-title":"A review of the incidence and risk factors for fibromyalgia and chronic widespread pain in population-based studies","volume":"161","author":"Creed","year":"2020","journal-title":"Pain"},{"key":"ref5","first-page":"27","article-title":"Epidemiological, pharmacological and sociodemographic characterisation of a population of 386 fibromyalgic patients referred to a tertiary pain Centre in Italy","volume":"37","author":"Martini","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10067-009-1094-2","article-title":"Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions","volume":"28","author":"Okifuji","year":"2009","journal-title":"Clin Rheumatol"},{"key":"ref7","first-page":"1097","article-title":"Stress biomarkers in individuals with fibromyalgia syndrome: a systematic review with meta-analysis","volume":"10","author":"Beiner","year":"2022","journal-title":"Pain"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1097\/j.pain.0000000000002510","article-title":"Potential role of blood biomarkers in patients with fibromyalgia: a systematic review with meta-analysis","volume":"163","author":"Kumbhare","year":"2022","journal-title":"Pain"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-981-19-7376-5_16","article-title":"A link between inflammatory mechanisms and fibromyalgia","volume-title":"Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders","author":"Bains","year":"2023"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int Anesthesiol Clin"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-017-1641-y","article-title":"Potential mediators between fibromyalgia and C-reactive protein: results from a large us community survey","volume":"18","author":"Feinberg","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"ref13","author":"Pamukcu","year":"2021"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/j.pain.0000000000002857","article-title":"Inflammatory markers in the diagnosis of fibromyalgia","volume":"23","author":"Khamisy-Farah","year":"2021","journal-title":"IMAJ"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.14744\/nci.2017.31644","article-title":"The relationship between serum leptin level and disease activity and inflammatory markers in fibromyalgia patients","volume":"5","author":"Ataoglu","year":"2018","journal-title":"Istanb Kuzey Klinikleri"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e74524","DOI":"10.1371\/journal.pone.0074524","article-title":"Fibromyalgia: anti-inflammatory and stress responses after acute moderate exercise","volume":"8","author":"Bote","year":"2013","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1600-0838.2010.01132.x","article-title":"Aquatic exercise improves the monocyte pro-and anti-inflammatory cytokine production balance in fibromyalgia patients","volume":"22","author":"Ortega","year":"2012","journal-title":"Scand J Med Sci Sports"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00296-012-2538-6","article-title":"Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, Interleukin-6, Interleukin-8, erythrocyte sedimentation rate","volume":"33","author":"Xiao","year":"2013","journal-title":"Rheumatol Int"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bbi.2019.12.020","article-title":"Peripheral immune aberrations in fibromyalgia: a systematic review, Meta-analysis and Meta-regression","volume":"87","author":"Andres-Rodriguez","year":"2020","journal-title":"Brain Behav Immun"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1590\/2359-3997000000248","article-title":"Serum levels of leptin and adiponectin and clinical parameters in women with fibromyalgia and overweight\/obesity","volume":"61","author":"Paiva","year":"2017","journal-title":"Archiv Endocrinol Metabol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jbspin.2007.01.024","article-title":"Serum ghrelin levels but not Gh, Igf-1 and Igfbp-3 levels are altered in patients with fibromyalgia syndrome","volume":"74","author":"Tander","year":"2007","journal-title":"Joint Bone Spine"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/jalm\/jfac076","article-title":"Crp and high-sensitivity Crp: \u201cWhat\u2019s in a name?\u201d","volume":"7","author":"Wolska","year":"2022","journal-title":"J Appl Lab Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbi.2019.06.010","article-title":"Patients with fibromyalgia and chronic fatigue syndrome show increased Hscrp compared to healthy controls","volume":"81","author":"Groven","year":"2019","journal-title":"Brain Behav Immun"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40814-022-01199-6","article-title":"The Perpain trial: a pilot randomized controlled trial of personalized treatment allocation for chronic musculoskeletal pain\u2014a protocol","volume":"8","author":"Beiner","year":"2022","journal-title":"Pilot Feasib Stud"},{"key":"ref25","first-page":"319","article-title":"Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume-title":"Seminars in Arthritis and Rheumatism","author":"Wolfe","year":"2016"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the Acr preliminary diagnostic criteria for fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthri Rheum"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1176\/appi.ajp.2012.12071000","article-title":"Dsm-5 field trials in the United States and Canada, part iii: development and reliability testing of a cross-cutting symptom assessment for Dsm-5","volume":"170","author":"Narrow","year":"2013","journal-title":"Am J Psychiatr"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamainternmed.2013.12179","article-title":"The somatic symptom scale\u20138 (Sss-8): a brief measure of somatic symptom burden","volume":"174","author":"Gierk","year":"2014","journal-title":"JAMA Intern Med"},{"key":"ref30","author":"Vuorre","year":"2017"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1037\/a0029146","article-title":"Bayesian estimation supersedes the T test","volume":"142","author":"Kruschke","year":"2013","journal-title":"J Exp Psychol Gen"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v080.i01","article-title":"Brms: An R package for Bayesian multilevel models using Stan","volume":"80","author":"B\u00fcrkner","year":"2017","journal-title":"J Stat Softw"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s10067-017-3647-0","article-title":"Evaluation of blood neutrophil-lymphocyte ratio and platelet distribution width as inflammatory markers in patients with fibromyalgia","volume":"36","author":"Akt\u00fcrk","year":"2017","journal-title":"Clin Rheumatol"},{"key":"ref34","first-page":"291","article-title":"Neurogenic inflammation in fibromyalgia","volume-title":"Seminars in immunopathology","author":"Littlejohn","year":"2018"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.18621\/eurj.376343","article-title":"The Association of Carotid Intima-Media Thickness with body mass index and cortisol level in fibromyalgia syndrome","volume":"5","author":"Koca","year":"2019","journal-title":"Eur Res J"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/1099800415591035","article-title":"Nitric oxide, inflammation, lipid profile, and cortisol in normal and overweight women with fibromyalgia","volume":"18","author":"Rus","year":"2016","journal-title":"Biol Res Nurs"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/acr.20653","article-title":"Association of Body Mass Index with symptom severity and quality of life in patients with fibromyalgia","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Care Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2147\/JPR.S55598","article-title":"The association between chronic pain and obesity","volume":"8","author":"Okifuji","year":"2015","journal-title":"J Pain Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s10067-008-0966-1","article-title":"A cross-sectional study of the relationship between body mass index and clinical characteristics, tenderness measures, quality of life, and physical functioning in fibromyalgia patients","volume":"27","author":"Neumann","year":"2008","journal-title":"Clin Rheumatol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-020-00582-9","article-title":"Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (Nafld): a United Kingdom population-based cohort study using the health improvement network (thin)","volume":"20","author":"Vusirikala","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"ref42","article-title":"Fibromyalgia","volume-title":"StatPearls. StatPearls Publishing, Treasure Island (FL)","author":"Bhargava","year":"2022"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"CD012332","DOI":"10.1002\/14651858.CD012638","article-title":"Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults","volume":"3","author":"Derry","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1237518\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T08:13:00Z","timestamp":1701331980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1237518\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":43,"alternative-id":["10.3389\/fpsyt.2023.1237518"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1237518","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"article-number":"1237518"}}